IndexMethodologyInsightsFor CliniciansRequest Review
Index/Memorial Sloan-Kettering Cancer Center
ALT-001180DEN170058Amber Status

Memorial Sloan-Kettering Cancer Center

MSK-IMPACT (Integrated Mutation Profiling of Actionable Cancer Targets):a Hybridization-Capture Based Next Generation Sequencing Assay

All identifiers (2)
Aletia (canonical)ALT-001180
FDA De Novo ยท US (primary)DEN170058

Regulatory Registrations

๐ŸŒ
US
FDA
ID: DEN170058
510k

Lifecycle Signals

Last Automated Sync
Mar 2026
Last Clinical Review
Not reviewed
This listing was auto-populated from public registry data
Some fields are incomplete or unverified. If you represent Memorial Sloan-Kettering Cancer Center, you can verify and update this listing.
Verify this listing โ†’
โ† Back to Index